Gilead Sciences: Diversification Strategy Not Derisked Enough Yet #Gilead #Sciences #Diversification #Strategy #Derisked
Tag: Gilead
Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) – Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark’s…
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
— Strategic Partnership Strengthens Gilead’s Inflammation Research Portfolio with the Addition of LEO Pharma’s Preclinical Oral…
Morgan Stanley upgrades Gilead on HIV treatment growth By Investing.com
Investing.com — Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:) to “overweight” from “equal weight,” raising its price…
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise
Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise #Gilead #Sciences #Preview #Buy #Thriving…